Kareem Abdul-Jabbar Discusses Living With CML

Kareem Abdul-Jabbar
Published: Friday, Mar 18, 2016



Kareem Abdul-Jabbar, retired NBA player for the Milwaukee Bucks and the Los Angeles Lakers, discusses his experience with chronic myeloid leukemia‎ (CML) at the 20th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas and Myeloma, held March 18, 2016.

While anyone is at risk for CML and other types of leukemia, it is a disease that is possible to live with and to overcome thanks to novel treatments that are now available, says Abdul-Jabbar. It important that patients with CML follow their doctors’ instructions closely, and keep up with all of their medications.

Drugs that target specific genetic abnormalities like nilotinib (Tasigna) and imatinib mesylate (Gleevec), which both treat Philadelphia chromosome-positive (Ph+) CML, are taking the right approach, says Abdul-Jabbar. These types of agents have promise across multiple tumor types, he says.

<<< View more from the 2016 Congress on Hematologic Malignancies



Kareem Abdul-Jabbar, retired NBA player for the Milwaukee Bucks and the Los Angeles Lakers, discusses his experience with chronic myeloid leukemia‎ (CML) at the 20th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas and Myeloma, held March 18, 2016.

While anyone is at risk for CML and other types of leukemia, it is a disease that is possible to live with and to overcome thanks to novel treatments that are now available, says Abdul-Jabbar. It important that patients with CML follow their doctors’ instructions closely, and keep up with all of their medications.

Drugs that target specific genetic abnormalities like nilotinib (Tasigna) and imatinib mesylate (Gleevec), which both treat Philadelphia chromosome-positive (Ph+) CML, are taking the right approach, says Abdul-Jabbar. These types of agents have promise across multiple tumor types, he says.

<<< View more from the 2016 Congress on Hematologic Malignancies


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x